Fernando Ovalle, MD

Professor of Medicine & Division Director
University of Alabama at Birmingham
Birmingham, AL, United States

Disclosure information not submitted.

Presentation(s):

• SUN-676 - A 12-Month Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study to Evaluate the Safety and Efficacy of Metreleptin in Subjects with Partial Lipodystrophy: The METRE-PL Study

  Sunday, June 14, 2026
  12:00 PM - 1:30 PM CT

• SUN-676 - A 12-Month Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study to Evaluate the Safety and Efficacy of Metreleptin in Subjects with Partial Lipodystrophy: The METRE-PL Study

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT

• ORF50 - Emerging and Established Pharmacotherapies

  Monday, June 15, 2026
  1:45 PM - 3:15 PM CT